Evidence map›Paper›PMID 26457672›Full record

ArticleJournal of innate immunity2016

Endotoxin Tolerance Inhibits Lyn and c-Src Phosphorylation and Association with Toll-Like Receptor 4 but Increases Expression and Activity of Protein Phosphatases.

Yanbao Xiong, Michael Murphy, Tissa T Manavalan, Goutham Pattabiraman, Fu Qiu, Hui-Hsin Chang, I-Cheng Ho, Andrei E Medvedev

Abstract read
In one paragraph

Article in Journal of innate immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yanbao XiongDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Md., USA.
Michael Murphy
Tissa T Manavalan
Goutham Pattabiraman
Fu Qiu
Hui-Hsin Chang
I-Cheng Ho
Andrei E Medvedev
UConn Health · USBrigham and Women's Hospital · USUniversity of Maryland, Baltimore · US

Funding

Effect of Bacterial Tolerance on TLR Signal TransductionR01AI059524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI MEDVEDEV, ANDREI E · 2005 to 2014
$2.6M
NIAID NIH HHS R01 AI059524NIAID NIH HHS R01AI059524
6 · The paper itself

Abstract

Endotoxin tolerance protects the host by limiting excessive 'cytokine storm' during sepsis, but compromises the ability to counteract infections in septic shock survivors. It reprograms Toll-like receptor (TLR) 4 responses by attenuating the expression of proinflammatory cytokines without suppressing anti-inflammatory and antimicrobial mediators, but the mechanisms of reprogramming remain unclear. In this study, we demonstrate that the induction of endotoxin tolerance in human monocytes, THP-1 and MonoMac-6 cells inhibited lipopolysaccharide (LPS)-mediated phosphorylation of Lyn, c-Src and their recruitment to TLR4, but increased total protein phosphatase (PP) activity and the expression of protein tyrosine phosphatase (PTP) 1B, PP2A, PTP nonreceptor type (PTPN) 22 and mitogen-activated protein kinase phosphatase (MKP)-1. Chemical PP inhibitors, okadaic acid, dephostatin and cantharidic acid markedly decreased or completely abolished LPS tolerance, indicating the importance of phosphatases in endotoxin tolerization. Overexpression of PTPN22 decreased LPS-mediated nuclear factor (NF)-x03BA;B activation, p38 phosphorylation and CXCL8 gene expression, while PTPN22 ablation upregulated LPS-induced p65 NF-x03BA;B and p38 phosphorylation and the expression of TNF-α and pro-IL-1β mRNA, indicating PTPN22 as an inhibitor of TLR4 signaling. Thus, LPS tolerance interferes with TLR4 signaling by inhibiting Lyn and c-Src phosphorylation and their recruitment to TLR4, while increasing the phosphatase activity and expression of PP2A, PTPN22, PTP1B and MKP1.

Indexed as

Cell Line, TumorCSK Tyrosine-Protein KinaseGene Expression Regulation, EnzymologicHumansImmune ToleranceLipopolysaccharidesMonocytesPhosphoprotein PhosphatasesSignal Transductionsrc-Family KinasesToll-Like Receptor 4CSK protein, humanCSK Tyrosine-Protein KinaseLipopolysaccharideslyn protein-tyrosine kinasePhosphoprotein Phosphatasessrc-Family KinasesTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID26457672
PMCPMC4801746
OpenAlexW1963062421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.